The development of ocular signs of neurofibromatosis type 1 (NF1) is only significant in patients 7 years of age and younger.

RXRX's CDK7 inhibitor REC-617 has demonstrated activity, but additional data from the ELUCIDATE trial in various solid tumors ...

Conference taking place on March 27-29, 2025 in New Orleans -- -- CAGLA NeauxCancer Conference is a leading global forum in ...

Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.

On Monday, activist Idelisa Diasniurka Salcedo Verdecia voiced her concerns regarding the chemotherapy administered to young ...

Positive updates continue to emerge from Nicklaus Children's Hospital in Miami, where young Damir Ortiz, a Cuban child in ...

Hereditary predisposition is a relevant cause of cancer in children and adolescents. At least 10% of all pediatric tumors are ...

BACKGROUND: Plexiform neurofibromas represent a common neoplasia of type 1 neurofibromatosis in which neurofibromas arise from multiple nerves involving connective tissue and skin and rarely affect ...

Ouardi, K. , Hamama, J. , Harbili, M. , Ouraini, S. , Benariba, F. and Errami, N. (2025) Silent Growth: 18-Year History of an Upper Lip Schwannoma. Voice of the Publisher, 11, 128-135. doi: 10.4236/vp ...

For five-year-old Bihan Biswas from Kolkata and his family, that future is characterised by fear, uncertainty, and a relentless battle against Neurofibromatosis Type 1 (NF1). NF1 is a rare genetic ...

We are grateful for the support from the Children’s Tumor Foundation, a vital partner in this journey, and to the Neurofibromatosis Clinical Trials Consortium for making this clinical trial a ...